Clinical Trial Update: Safety and Efficacy Study of Pracinostat With Azacitadine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML) [Phase 2]

View source ↗

Summary

Phase 2 safety and efficacy study of pracinostat with azacitidine in elderly patients with newly diagnosed acute myeloid leukemia completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Pracinostat (pracinostat)

Snippet

Sponsor: Helsinn Healthcare SA | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2021-02-09